Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jaroslaw Bogaczewicz"'
Autor:
Ewa Robak, Zofia Gerlicz-Kowalczuk, Bożena Dziankowska-Bartkowiak, Anna Wozniacka, Jaroslaw Bogaczewicz
Publikováno v:
Archives of Medical Science, Vol 15, Iss 3, Pp 706-712 (2019)
Externí odkaz:
https://doaj.org/article/751109a2efd34ded8346a9cb8bb67672
Autor:
Anna Bogaczewicz, Tomasz Sobow, Jan Kowalski, Jakub Ząbek, Anna Woźniacka, Jaroslaw Bogaczewicz
Publikováno v:
Rheumatology, Vol 53, Iss 3, Pp 131-138 (2015)
Objectives: To relate the cognitive parameters of systemic lupus erythematosus (SLE) patients in remission to their profile of autoantibodies. Material and methods : The study included 32 patients with SLE in remission, with mild disease activity as
Externí odkaz:
https://doaj.org/article/c8208e05d69c43b0804bff3111242a06
Autor:
Jaroslaw Bogaczewicz, Elzbieta Karczmarewicz, Pawel Pludowski, Jakub Zabek, Jan Kowalski, Jacek Lukaszkiewicz, Anna Wozniacka
Publikováno v:
Revista Brasileira de Reumatologia, Vol 55, Iss 2, Pp 133-139 (2015)
Objetivo: Investigar a viabilidade dos marcadores de remodelação óssea (MRO) na avaliação do metabolismo ósseo em pacientes com lúpus eritematoso sistêmico (LES), de acordo com as diretrizes da International Osteoporosis Foundation e da Inter
Externí odkaz:
https://doaj.org/article/5694c652570d4b0fbe6dac16e419aaef
Autor:
Jaroslaw Bogaczewicz, Elzbieta Karczmarewicz, Pawel Pludowski, Jakub Zabek, Jan Kowalski, Jacek Lukaszkiewicz, Anna Wozniacka
Publikováno v:
Revista brasileira de reumatologia. 55(2)
ObjectiveTo investigate the feasibility of bone turnover markers for the assessment of bone metabolism in patients with systemic lupus erythematosus, according to the guidelines of the International Osteoporosis Foundation and the International Feder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be1fbf13f50dcc41fc4a663ca85debb
https://pubmed.ncbi.nlm.nih.gov/25583000
https://pubmed.ncbi.nlm.nih.gov/25583000
Publikováno v:
Przegląd Dermatologiczny, Vol 107, Iss 2, Pp 148-158 (2020)
Externí odkaz:
https://doaj.org/article/de46892ef17148f0a118eca1b532fb2a
Publikováno v:
Przegląd Dermatologiczny, Vol 106, Iss 4, Pp 396-404 (2019)
Externí odkaz:
https://doaj.org/article/3d351c8d33984e6dafb23fbfcb6c050c
Autor:
Agata Liszewska, Ewa Robak, Małgorzata Bernacka, Anna Woźniacka, Jarosław Bogaczewicz, Krzysztof Chojnowski
Publikováno v:
Przegląd Dermatologiczny, Vol 106, Iss 3, Pp 302-309 (2019)
Externí odkaz:
https://doaj.org/article/7c56bb54a8a243a8bd26b3bb1326a722
Publikováno v:
Przegląd Dermatologiczny, Vol 106, Iss 3, Pp 257-267 (2019)
Externí odkaz:
https://doaj.org/article/affdb70a600f47a48a51e67184d8f735
Publikováno v:
Przegląd Dermatologiczny, Vol 106, Iss 2, Pp 210-216 (2019)
Externí odkaz:
https://doaj.org/article/52cbfef9e50f488caeb77da73594bb37
Publikováno v:
Przegląd Dermatologiczny, Vol 105, Iss 6, Pp 710-715 (2019)
Narrow band (311 nm) UVB phototherapy is established treatment for psoriasis. DNA is a target for UVB via formation of cyclobutane pyrimidine dimers, which trigger loss of dendritic cells and macrophages, and inhibit CD4+ and CD8+ T cells. UV causes
Externí odkaz:
https://doaj.org/article/3330c58b1f514bc8b087ad0cce00da82